Thrombectomy Devices Market will Likely to Expand at a Steady CAGR of 5.9% Between 2019 and 2027

An exclusive Thrombectomy Devices Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Thrombectomy Devices Market by Type, By Application, By Region – North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Thrombectomy Devices Market. Additionally, the report also highlights market entry strategies for various companies across the globe.

The global Thrombectomy Devices market is anticipated to reach US$ 2,101.29 Mn in 2027 from US$ 1,282.07 Mn in 2018. The market is anticipated to grow with a CAGR of 5.9% from 2019-2027.

Get Sample Copy of this Report at

Growth strategies through several organic and inorganic such as approvals, product launch, agreements, and partnerships have been witnessed in the market of Thrombectomy Devices. For instance, in July, 2018, Johnson & Johnson a medical device company has launched EMBOTRAP II Revascularization Device under the Cerenovus business segment. EMBOTRAP II is a new device for treating stroke patients and advancement in mechanical thrombectomy.

Leading Thrombectomy Devices Market Players:

  1. Penumbra, Inc.
  2. Stryker Corporation
  3. Medtronic
  4. Edward Lifesciences Corporation
  5. Terumo Corporation
  6. Koninklijke Philips N.V.
  7. Teleflex Incorporated
  8. Johnson & Johnson Services, Inc.
  9. Inari Medical
  10. Argon Medical

Market Insights

Favorable Medical Reimbursement Scenario

In January 2018, European Tech Reimbursement Consulting (MTRC) released a 62-page reimbursement report for mechanical thrombectomy for stroke. The report covers procedure coding, payment mechanism, reimbursement tariffs, and policy restrictions in 11 EU countries, including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden, and Switzerland. The report also covers essential information about reimbursement and national funding, including a brief overview of reimbursement system for medical devices, procedure coding for technology, diagnosis coding, payment mechanism for technology, reimbursement tariffs for technology, restrictions in indications or scenarios for use of technology, and technology-related policy considerations by payers and policymakers.

Market Segmentation

Global Thrombectomy Devices Market – By Type

  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic Thrombectomy Devices
  • Ultrasonic Thrombectomy Devices

Global Thrombectomy Devices Market – By Application

  • Cardiovascular
  • Peripheral Vascular
  • Neurovascular

Global Thrombectomy Devices Market – By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Academic & Research Institutes

If You want to Purchase the Report Directly:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

Call: +1-646-491-9876